AURA — AURA BIOSCIENCES Cashflow Statement
0.000.00%
Last trade - 00:00- $309.15m
- $158.06m
- 39
- 21
- 50
- 29
Annual cashflow statement for AURA BIOSCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22.2 | -35.3 | -58.8 | -76.4 | -86.9 |
| Depreciation | |||||
| Non-Cash Items | 0.733 | 2.33 | 6.09 | 6.83 | 8.53 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.68 | -0.315 | -3.1 | 4.44 | -2.64 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -24.3 | -32.4 | -54.6 | -63.8 | -79.8 |
| Capital Expenditures | -0.771 | -2.13 | -1.09 | -0.709 | -1.25 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -66.8 | -113 | 70.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.771 | -2.13 | -67.9 | -114 | 68.8 |
| Financing Cash Flow Items | — | -0.015 | 0 | 0.128 | 0.177 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10 | 166 | 95.6 | 97.3 | 1.59 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.1 | 132 | -26.8 | -80.5 | -9.39 |